Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225966 · ClinicalTrials.gov registry record · NA
Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT00225966: Clinical Trial NA study, sponsored by MedtronicNeuro.
NCT00225966 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00225966, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is assess the long-term safety and effectiveness of the InterStim tined lead using a minimally invasive approach.
Interventions
- DEVICE Device Medtronic InterStim Tined Leads Models 3889 and 3093
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-10 |
| Phase | NA |
Why NCT00225966 stopped before completion
NCT00225966 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Device Medtronic InterStim Tined Leads Models 3889 and 3093 is the first listed.
NCT00225966 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00225966 about?
NCT00225966 is a clinical study titled "Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control". The purpose of this study is assess the long-term safety and effectiveness of the InterStim tined lead using a minimally invasive approach.
What is the current status of trial NCT00225966?
This trial is currently terminated. It is a NA study. The enrollment target is 153 participants. The study started on 2004-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00225966?
The interventions under investigation include: Device Medtronic InterStim Tined Leads Models 3889 and 3093 (DEVICE).
Who is sponsoring clinical trial NCT00225966?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00225966's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia